Vyxeos Interactions
There are 522 drugs known to interact with Vyxeos (cytarabine liposomal/daunorubicin liposomal), along with 6 disease interactions. Of the total drug interactions, 113 are major, 402 are moderate, and 7 are minor.
- View all 522 medications that may interact with Vyxeos
- View Vyxeos disease interactions (6)
Most frequently checked interactions
View interaction reports for Vyxeos (cytarabine liposomal / daunorubicin liposomal) and the medicines listed below.
- Abbokinase (urokinase)
- acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine
- Actiq (fentanyl)
- Activase (alteplase)
- Adriamycin (doxorubicin)
- Arixtra (fondaparinux)
- atomoxetine
- Azedra (iobenguane I 131)
- Azilect (rasagiline)
- azithromycin
- bleomycin
- Blocadren (timolol)
- Bosulif (bosutinib)
- calcitonin
- Cepastat Sore Throat & Cough (benzocaine / dextromethorphan / menthol topical)
- Ceprotin (protein c)
- Coreg CR (carvedilol)
- cyclophosphamide
- cycloserine
- DepoCyt (cytarabine liposomal)
- Desoxyn Gradumet (methamphetamine)
- dexamethasone
- Dibenzyline (phenoxybenzamine)
- Dilantin (phenytoin)
- Edurant (rilpivirine)
- Eliquis (apixaban)
- Etopophos (etoposide)
- Evrysdi (risdiplam)
- fluoride
- Givlaari (givosiran)
Vyxeos disease interactions
There are 6 disease interactions with Vyxeos (cytarabine liposomal / daunorubicin liposomal) which include:
- infections
- meningeal infection
- myelosuppression
- congestive heart failure
- infections
- myelosuppression
Report options
QR code containing a link to this page
More about Vyxeos (cytarabine liposomal / daunorubicin liposomal)
- Vyxeos consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antineoplastic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.